AAAlaa Alhazmi

Alaa Alhazmi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alaa Alhazmi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative Evaluation of Cardiovascular Biomarkers in Diabetic and Non-Diabetic Myocardial Infarction Patients in Saudi Arabia

    by Mohammad Shane Alam, Yahia Ali Kaabi, Fakhra Jabeen, Mohammad Mazharul Hoque, Alaa Alhazmi, Mohammad Suhail Akhter, Yahia Mjery, Kamal Upreti, Rituraj Jain

    This study discusses the effect of diabetes mellitus (DM) and the importance of biochemical markers in the timely diagnosis, management and prognostication of acute myocardial infarction (AMI) through the measurement of cardiac enzymes in diabetic and non-diabetic patients with AMI.A cohort of 300 individuals of ages of 55-80 years were selected for case control study. Three groups of participants were identified: normal (N), Diabetic Acute Myocardial Infarction (D-AMI), and Non-diabetic Acute Myocardial Infarction (ND-AMI).Each participant underwent a thorough history, medical evaluation, and assessment of cardiovascular parameters.These parameters included fasting blood glucose, glycated hemoglobin (HbA1c), systolic and diastolic blood pressure, total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and the ratios of TC/HDL and LDL/HDL.The cardiac biomarkers measured included aspartate aminotransferase (AST), lactate dehydrogenase (LDH), C-reactive protein (CRP), creatine phosphokinase (CPK), creatine kinase-MB (CK-MB), and troponin-I.While TC, TG, and LDL-C levels were high, HDL-C levels were considerably lower in the D-AMI group than in the N-AMI group. Irrespective of whether they had diabetes mellitus, the study's findings demonstrated that individuals with myocardial infarction had considerably higher rates of cardiac biomarkers, including troponin I, CPK, CK-MB, AST, LDH, and CRP.Research indicates that individuals with D-AMI have higher cardiac indicators than those with ND-AMI.

  • Spleen Tyrosine Kinase as a Target Therapy for Pseudomonas aeruginosa Infection

    by Alaa Alhazmi

    Spleen tyrosine kinase (SYK) is a nonreceptor tyrosine kinase which associates directly with extracellular receptors, and is critically involved in signal transduction pathways in a variety of cell types for the regulation of cellular responses. SYK is expressed ubiquitously in immune and nonimmune cells, and has a much wider biological role than previously recognized. Several studies have highlighted SYK as a key player in the pathogenesis of a multitude of diseases. Pseudomonas aeruginosa is an opportunistic gram-negative pathogen, which is responsible for systemic infections in immunocompromised individuals, accounting for a major cause of severe chronic lung infection in cystic fibrosis patients and subsequently resulting in a progressive deterioration of lung function. Inhibition of SYK activity has been explored as a therapeutic option in several allergic disorders, autoimmune diseases, and hematological malignancies. This review focuses on SYK as a therapeutic target, and describes the possibility of how current knowledge could be translated for therapeutic purposes to regulate the immune response to the opportunistic pathogen P. aeruginosa.


  • NOD-like receptor(s) and host immune responses with Pseudomonas aeruginosa infection

    by Alaa Alhazmi

    Molecular mechanisms underlying the interactions between Pseudomonas aeruginosa, the common opportunistic pathogen in cystic fibrosis individuals, and host induce a number of marked inflammatory responses and associate with complex therapeutic problems due to bacterial resistance to antibiotics in chronic stage of infection.


  • Open Access

    Pseudomonas aeruginosa – Pathogenesis and Pathogenic Mechanisms

    by Alaa Alhazmi

    Pseudomonas aeruginosa is a common bacterium, Gram-negative opportunistic pathogen capable of infecting humans with compromised natural defenses and causing severe pulmonary disease. It is one of the leading pathogen associated with nosocomial infections. It has a vast arsenal of pathogenicity factors that are used to interfere with host defenses. Pathogenesis in P. aeruginosa facilitates adhesion, modulate or disrupt host cell pathways, and target the extracellular matrix. The propensity of P. aeruginosa to form biofilms further protects it from antibiotics and the host immune system. P. aeruginosa is intrinsically resistant to a large number of antibiotics and can be acquired resistance to many others, making treatment difficult. P. aeruginosa provokes a potent inflammatory response during the infectious process. The majority of mortalities in immunocompromised patients; cystic fibrosis, can be attributed to the progressive decline of lung function resulting from chronic infection by pathogens such as P. aeruginosa . Antibiotic treatment of chronic P. aeruginosa infections may temporarily suppress symptoms; however, they do not eradicate the pathogen. Lung diseases caused by P. aeruginosa are a leading cause of death in immunocompromised individuals as well as in children. Although immunocytes recruitment is critical to augment the host defense, excessive neutrophil accumulation results in life-threatening diseases, such as acute lung injury, as well as acute respiratory distress syndrome. Several virulence factors have been studied for their roles as potential vaccine candidate, although there is currently no clinically accepted vaccine. Understanding host-pathogen interaction is critical for the development of effective therapeutic strategies to control the damage in the lung.